Hoth Therapeutics, Inc. - Common Stock (HOTH)
0.6459
+0.1340 (26.18%)
NASDAQ · Last Trade: Apr 15th, 1:27 AM EDT
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · April 14, 2026
Get a pulse on the US markets on Tuesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Via Chartmill · April 14, 2026
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · April 14, 2026
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Via Chartmill · April 14, 2026
Top movers analysis one hour before the close of the markets on 2026-04-01: top gainers and losers in today's session.chartmill.com
Via Chartmill · April 1, 2026
The company announced positive preclinical results from a study evaluating GDNF as a potential treatment for obesity and metabolic-associated steatotic liver disease.
Via Stocktwits · February 10, 2026
3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.
Via MarketBeat · September 9, 2025
Via Benzinga · September 2, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · September 2, 2025
Hoth Therapeutics reported strong preclinical efficacy and safety data for HT-KIT, a precision antisense therapy targeting KIT-driven cancers.
Via Benzinga · September 2, 2025
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
Via Benzinga · August 28, 2025
Unusual volume stocks in Friday's session
Via Chartmill · June 6, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · June 5, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via Chartmill · June 4, 2025

Via Benzinga · June 4, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 4, 2025
Via Benzinga · April 17, 2025

Via Benzinga · January 8, 2025

Via Benzinga · January 8, 2025

Via Benzinga · January 7, 2025

Hoth Therapeutics' HT-001 shows promising interim Phase 2a trial results, improving skin toxicities in cancer patients without treatment-related adverse effects.
Via Benzinga · January 7, 2025

Via Benzinga · January 7, 2025


